“…Several of the 74 genes are implicated in disorders of the human nervous system, including childhood neurodevelopmental disorders, such as Autism spectrum disorders (ASD), syndromic and nonsyndromic mental retardation (MR), and late-onset neurodegenerative processes, including frontotemporal lobar degeneration (FTLD), amyotrophic lateral sclerosis (ALS), and Huntington and Parkinson diseases (Table S4). Several genes within this group, including TARDBP, TIAL1, SIRT1, and PQBP1, which have recently been implicated in neurodegenerative diseases (ALS/FTLD spectrum, SMA, Lewy Body Dementia, Parkinson disease, MR, respectively), are involved in mRNA trafficking, stability, and microRNA biogenesis, associated with various types of RNA granules or involved in protein misfolding (25,26). Silencing of additional genes within these pathways (e.g., G3BP1, TAF15, and SNRPB2) in our shRNA screen displayed different PSA-NCAM phenotypes (Table S5), in line with the interaction and differential regulation of RNA granule components (27).…”